Title:
CRYSTALLINE FORM OF QUINOLINE DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/046292
Kind Code:
A1
Abstract:
The present invention relates to the technical field of medicines, and in particular, to a mesylate crystalline form of a TAM family kinase and/or CSF1R kinase and/or NTRK inhibitor shown in a formula (I), a preparation method therefor and a pharmaceutical use thereof.
Inventors:
KANG SISHUN (CN)
YUAN JIADONG (CN)
LI LIN (CN)
YUAN JIADONG (CN)
LI LIN (CN)
Application Number:
PCT/CN2023/115393
Publication Date:
March 07, 2024
Filing Date:
August 29, 2023
Export Citation:
Assignee:
TRANSTHERA SCIENCES NANJING INC (CN)
International Classes:
C07D401/14; A61K31/4709; A61K31/501; A61K31/506; A61P15/00; A61P35/00; C07D491/056
Domestic Patent References:
| WO2020038460A1 | 2020-02-27 | |||
| WO2022095910A1 | 2022-05-12 | |||
| WO2014145015A2 | 2014-09-18 | |||
| WO2014018535A1 | 2014-01-30 | |||
| WO2018139527A1 | 2018-08-02 | |||
| WO2018214867A1 | 2018-11-29 |
Foreign References:
| CN107667101A | 2018-02-06 |
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF:
Previous Patent: FUNCTIONAL MOUTHPIECE
Next Patent: DISTRIBUTION BOX HAVING DATA INTERACTION FUNCTION
Next Patent: DISTRIBUTION BOX HAVING DATA INTERACTION FUNCTION